文献速递淋巴瘤

原发性胃弥漫大B细胞淋巴瘤:一项多中心回顾性研究

Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study.
PubMed 文献 · Br J Haematol · 2024-04-17

研究纳入2006至2018年澳大利亚、加拿大和丹麦六中心37例I期原发性胃弥漫大B细胞淋巴瘤患者,中位随访42.2个月,评估 outcomes、治疗及中期PET作用。所有患者接受化学免疫治疗,91.9%用R-CHOP,35.1%接受巩固放疗,R-CHOP的4年无进展生存和总生存分别为88%和91%。中期PET达部分或完全代谢缓解者最终均达完全缓解。

要点

  • I期原发性胃DLBCL患者接受R-CHOP为基础的化学免疫治疗,4年PFS为88%,OS为91%。
  • 中期PET评估达部分或完全代谢缓解的患者,治疗结束时均达完全缓解。
  • 放疗和幽门螺杆菌根除治疗按个案情况实施。

核心结论

  • R-CHOP为基础的化学免疫治疗联合中期PET评估似乎可带来良好结局,放疗和幽门螺杆菌根除治疗按个案情况实施。

研究设计与样本

  • 多中心回顾性研究,纳入2006至2018年澳大利亚、加拿大和丹麦六中心37例I期原发性胃弥漫大B细胞淋巴瘤患者。

主要发现

  • 中位随访42.2个月。
  • 所有患者接受化学免疫治疗,91.9%(n=34)接受R-CHOP方案。
  • 35.1%(n=13)接受巩固放疗。
  • 18例幽门螺杆菌阳性,11例有幽门螺杆菌根除治疗记录。
  • R-CHOP的4年无进展生存率为88%(95% CI:71-95),总生存率为91%(95% CI:75-97)。

关键数值与推荐

  • R-CHOP的4年无进展生存率为88%(95% CI:71-95),总生存率为91%(95% CI:75-97)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary gastric diffuse large B-cell lymphoma (PG-DLBCL) accounts for the majority of extra-nodal DLBCL. Even so, literature is lacking on early, localised presentations. We studied a cohort of patients with stage I disease, diagnosed between 2006 and 2018, from six centres between Australia, Canada and Denmark. Our goal was to characterise outcomes, review treatment and investigate the role of interim positron emission tomography (iPET). Thirty-seven eligible patients were identified. The median duration of follow-up was 42.2 months. All received chemoimmunotherapy with 91.9% (n = 34) given rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP). 35.1% (n = 13) underwent consolidative radiotherapy. Eighteen patients were H. pylori positive and 11 had the documentation of H. pylori eradication therapy. The 4-year progression-free survival and overall survival of R-CHOP was 88% (95% CI: 71-95) and 91% (95% CI: 75-97) respectively. All patients who achieved a partial metabolic response or complete metabolic response on iPET went on to achieve complete response at the end of treatment. R-CHOP-based therapy with iPET assessment appears to offer favourable outcomes, with radiotherapy and H. pylori eradication therapy implemented on a case-by-case basis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Lewis CS, Joy G, Jensen P, et al. Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study. Br J Haematol. 2024. PMID: 38632873. doi:10.1111/bjh.19470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。